Skip to content

Barbed Suture vs Smooth Suture for Vaginal Cuff Closure

Barbed Suture vs Smooth Suture for Vaginal Cuff Closure, a Randomized Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01262573
Enrollment
64
Registered
2010-12-17
Start date
2010-12-31
Completion date
2012-11-30
Last updated
2017-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Closure of Vaginal Cuff at Laparoscopic Hysterectomy

Brief summary

This study compares outcomes among patients having a total laparoscopic hysterectomy. This involves removing the uterus and cervix using a laparoscopic or keyhole technique. The top of the vagina is routinely sutured closed after this procedure and this study is comparing two different suture materials for this purpose. One suture material is a barbed suture that has the advantage of maintaining good tension and closure on the wound. The other is a standard smooth suture that is commonly used for this procedure. The investigators are comparing the time it takes to close the vaginal cuff, as well as bleeding after surgery and the healing of the top of the vagina.

Detailed description

Barbed suture has been used to close the vaginal vault for almost 3 years now, and a few preliminary studies report positive outcomes. Unfortunately, the retrospective nature of these studies may present outcomes in an overly positive light, since some of the patients may not be able to remember all the potential complications or problems they may have had in the immediate postoperative period (recall bias). The current standard of care for vaginal cuff closure appears to be to use Vicryl suture although practices vary widely. The specific aim of this study is to evaluate whether the use of barbed suture facilitates the laparoscopic closure of the vaginal cuff during a total laparoscopic hysterectomy. The inclusion criteria for our study include all patients who are planned for a total laparoscopic hysterectomy due to benign conditions such as symptomatic uterine fibroids, abnormal uterine bleeding, endometriosis and pelvic pain. The laparoscopic hysterectomy will proceed as per routine. For vaginal cuff closure with barbed suture we will use a 0 polydioxanone (PDO) bidirectional barbed suture on a 36 mm half-circle taper point needle. For cuff closure with Vicryl, we plan to use 2/0 Vicryl with the vaginal cuff closure proceeding in a similar fashion as with the barbed suture. Regardless of suture material used it is important to obtain a full thickness bite with a 1 cm margin on the vagina mucosa on each bite. Patients will be stratified to either closure by the attending or the resident or fellow under the supervision of the attending. The resident or fellow will have 15 minutes to complete the vaginal cuff closure. If they are not able to complete it within that time frame, the attending will take over and complete the vaginal cuff closure. This is to avoid adding excess operating time to the procedure due to having a trainee performing a portion of the procedure. Patients will also be asked to complete a short survey regarding dyspareunia as well as a standardized sexual function questionnaire (FSFI) prior to surgery and 3 months after surgery to evaluate if the use of barbed suture affects this in any way. Further we will also inquire about male dyspareunia before and after surgery for the same reason. Patients will be examined at a postoperative visit 3 weeks after surgery and vaginal cuff granulation and any evidence of vaginal cuff infection or separation will be carefully examined and documented. Patients will be called 3 months after surgery to inquire about any dyspareunia, male dyspareunia, vaginal bleeding or readmissions to the hospital. We are interested in evaluating dyspareunia, since a concern has been raised that the use of barbed suture at the vaginal apex may result in dyspareunia and partner dyspareunia. Although we have not found this to be the case in our clinical experience we would like to evaluate this point, especially since the use of barbed suture for closing the vaginal cuff has become a common practice nationwide. Patients will be dismissed from the trial after the 3 month follow up.

Interventions

PROCEDUREClosure of vaginal cuff

Closure of the vaginal cuff

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients having a total laparoscopic hysterectomy for benign conditions

Exclusion criteria

* Malignancy

Design outcomes

Primary

MeasureTime frameDescription
Vaginal Cuff Closure TimeDuring the surgical procedureAverage time (measured in minutes)

Secondary

MeasureTime frameDescription
DyspareuniaPostoperativeAssessed preoperatively and up to 3 months postop

Countries

United States

Participant flow

Participants by arm

ArmCount
Barbed
Vaginal cuff closure with barbed suture Closure of vaginal cuff: Closure of the vaginal cuff
32
Smooth
Vaginal cuff closure with smooth suture Closure of vaginal cuff: Closure of the vaginal cuff
31
Total63

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicSmoothTotalBarbed
Age, Continuous43.2 years
STANDARD_DEVIATION 8.1
44.7 years
STANDARD_DEVIATION 0.71
46.1 years
STANDARD_DEVIATION 5.6
BMI26.9 kg/m^2
STANDARD_DEVIATION 8.6
28.0 kg/m^2
STANDARD_DEVIATION 4.2
29.1 kg/m^2
STANDARD_DEVIATION 5.9
Cuff closure performed by the Attending Surgeon or the Fellow/Resident
Attending
15 participants31 participants16 participants
Cuff closure performed by the Attending Surgeon or the Fellow/Resident
Fellow/Resident
16 participants32 participants16 participants
Gender
Female
31 Participants63 Participants32 Participants
Gender
Male
0 Participants0 Participants0 Participants
Hospital
Army Hospital
13 participants27 participants14 participants
Hospital
Brigham and Women's Hospital
11 participants22 participants11 participants
Hospital
Faulkner Hospital
7 participants14 participants7 participants
Marital Status - Married12 participants23 participants11 participants
Medical History
Abnormal Uterine Bleeding
24 participants51 participants27 participants
Medical History
Fibroids
20 participants41 participants21 participants
Medical History
Infertility
2 participants5 participants3 participants
Medical History
Pelvic Pain
24 participants47 participants23 participants
Medical History
Prior Laparoscopy
12 participants27 participants15 participants
Medical History
Prior Laparotomy
19 participants31 participants12 participants
Medical History
Prolapse
0 participants0 participants0 participants
Parity1.7 Births
STANDARD_DEVIATION 1
1.7 Births
STANDARD_DEVIATION 0
1.7 Births
STANDARD_DEVIATION 1.3
Race/Ethnicity, Customized
Asian
1 participants3 participants2 participants
Race/Ethnicity, Customized
Black
8 participants16 participants8 participants
Race/Ethnicity, Customized
Hispanic
2 participants4 participants2 participants
Race/Ethnicity, Customized
Other
1 participants1 participants0 participants
Race/Ethnicity, Customized
Unknown
0 participants1 participants1 participants
Race/Ethnicity, Customized
White
19 participants38 participants19 participants
Region of Enrollment
United States
31 participants63 participants32 participants
Sexual Function
Any female dyspareunia reported
13 participants25 participants12 participants
Sexual Function
Any male dyspareunia reported
0 participants0 participants0 participants
Sexual Function
Ongoing problem
0 participants5 participants5 participants
Sexual Function
Other
0 participants0 participants0 participants
Smoking Status - Smoker7 participants9 participants2 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 320 / 31
serious
Total, serious adverse events
0 / 320 / 31

Outcome results

Primary

Vaginal Cuff Closure Time

Average time (measured in minutes)

Time frame: During the surgical procedure

ArmMeasureValue (MEAN)Dispersion
BarbedVaginal Cuff Closure Time10.4 minutesStandard Deviation 5.2
SmoothVaginal Cuff Closure Time9.6 minutesStandard Deviation 4.8
Secondary

Dyspareunia

Assessed preoperatively and up to 3 months postop

Time frame: Postoperative

ArmMeasureGroupValue (NUMBER)
BarbedDyspareuniaAny female dyspareunia reported2 participants
BarbedDyspareuniaOther3 participants
BarbedDyspareuniaAny male dyspareunia reported1 participants
BarbedDyspareuniaOngoing problem0 participants
SmoothDyspareuniaOther0 participants
SmoothDyspareuniaOngoing problem1 participants
SmoothDyspareuniaAny male dyspareunia reported0 participants
SmoothDyspareuniaAny female dyspareunia reported1 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026